Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × Cyclophosphamide × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Lymphoma, Large B-Cell, Diffuse 19 Lymphoma 18 Burkitt Lymphoma 18 Lymphoma, Follicular 15 Neoplasms 14 Leukemia, Myeloid, Acute 14 Lymphoma, Non-Hodgkin 13 Leukemia, Lymphocytic, Chronic, B-Cell 13 Breast Neoplasms 12 Recurrence 10 Melanoma 10 Hodgkin Disease 9 Myelodysplastic Syndromes 8 Ovarian Neoplasms 7 Lymphoma, B-Cell, Marginal Zone 7 Lymphoma, B-Cell 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Biphenotypic, Acute 7 Leukemia 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Sarcoma 5 Rhabdomyosarcoma 5 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Lymphoma, Mantle-Cell 5 Hematologic Neoplasms 5 Sarcoma, Ewing 4 Neuroblastoma 4

Interventions

durvalumab 3 Fulvestrant 3 Carboplatin 3 pembrolizumab 2 Pemetrexed 2 Cisplatin 2 trametinib 1 ribociclib 1 pralsetinib 1 palbociclib 1 exemestane 1 darolutamide 1 dabrafenib 1 ceralasertib 1 STX-478 1 Radiosurgery 1 Paclitaxel 1 Letrozole 1 Immunotherapy 1 Gemcitabine 1 Cetuximab 1 Anastrozole 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡